Kanemitsu Yoshitomi 金光祥臣

… Alternative Names

KANEMITSU Yoshitomi 金光祥臣

Less

Researcher Number	30752943
Other IDs
Affiliation (Current)	2025: 新潟大学, 医歯学総合病院, 准教授
Affiliation (based on the past Project Information) *help	2023: 新潟大学, 医歯学系, 助教 2019 – 2022: 新潟大学, 医歯学総合病院, 特任助教 2016 – 2017: 東北大学, 薬学研究科, 助手
Review Section/Research Field	Principal Investigator Basic Section 52040:Radiological sciences-related / Medical Physics and Radiological Technology
Keywords	Principal Investigator プロテオミクス / 放射線耐性細胞 / メタボロミクス / iMPAQT / トランスオミクス / TXNDC5 / オミクス解析 / Prx4 / PDI / peroxiredoxin / がん細胞 / 脂肪酸合成酵素 / 放射線耐性

トランスオミクス解析によるがん細胞の放射線耐性応答ネットワーク解明Principal Investigator
- Principal Investigator
  
  金光祥臣
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 52040:Radiological sciences-related
- Research Institution
  Niigata University
Development of new therapeutic strategies to overcome cancer radioresistance; focusing on molecules that are increased in resistant cell linesPrincipal Investigator
- Principal Investigator
  
  KANEMITSU Yoshitomi
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 52040:Radiological sciences-related
- Research Institution
  Niigata University
Elucidation of the mechanism of radioresistance in cancer cells using trans-omics approach and development of clinical biomarkers for radiotherapy.Principal Investigator
- Principal Investigator
  
  Kanemitsu Yoshitomi
- Project Period (FY)
  2016 – 2017
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Medical Physics and Radiological Technology
- Research Institution
  Tohoku University

All 2024 2023 2022 2021 2019 2018 2017 Other

All Journal Article Presentation Other

[Journal Article] Methylmercury directly modifies the 105th cysteine residue in oncostatin M to promote binding to tumor necrosis factor receptor 3 and inhibit cell growth2023
- Author(s)
  Toyama Takashi、Xu Sidi、Kanemitsu Yoshitomi、Hasegawa Takashi、Noguchi Takuya、Lee Jin-Yong、Matsuzawa Atsushi、Naganuma Akira、Hwang Gi-Wook
- Journal Title
  
  Archives of Toxicology
  
  Volume: 97 Issue: 7 Pages: 1887-1897
- DOI
  10.1007/s00204-023-03520-5
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K07713, KAKENHI-PROJECT-23K25006
[Journal Article] The Disease-modifying Drug Candidate, SAK3 Improves Cognitive Impairment and Inhibits Amyloid beta Deposition in App Knock-in Mice.2018
- Author(s)
  Izumi H, Shinoda Y, Saito T, Saido TC, Sato K, Yabuki Y, Matsumoto Y, Kanemitsu Y, Tomioka Y, Abolhassani N, Nakabeppu Y, Fukunaga K.
- Journal Title
  
  Neuroscience.
  
  Volume: 377 Pages: 87-97
- DOI
  10.1016/j.neuroscience.2018.02.031
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K15456, KAKENHI-PROJECT-17H01391, KAKENHI-PROJECT-16J02855, KAKENHI-PROJECT-16K20909, KAKENHI-PROJECT-16H05219
[Journal Article] Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach2017
- Author(s)
  †Mishima, E., †Fukuda, S. (†equally contributed), Mukawa, C., Yuri, A., Kanemitsu, Y., Matsumoto, Y., Akiyama, Y., Fukuda, NN., Tsukamoto, H., Asaji, K., Shima, H., Kikuchi, K., Suzuki, T., Tomioka, Y., Soga, T., Ito, S., Abe, T.
- Journal Title
  
  Kidney International
  
  Volume: 92 Issue: 3 Pages: 634-645
- DOI
  10.1016/j.kint.2017.02.011
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16H04901, KAKENHI-PROJECT-16K19474, KAKENHI-PROJECT-16K20909
[Journal Article] An inhibitory epitope of human Toll-like receptor 4 resides on leucine-rich repeat 13 and is recognized by a monoclonal antibody2017
- Author(s)
  Tsukamoto Hiroki、Yamagata Yuki、Ukai Ippo、Takeuchi Shino、Okubo Misaki、Kobayashi Yohei、Kozakai Sao、Kubota Kanae、Mumasaki Muneo、Kanemitsu Yoshitomi、Matsumoto Yotaro、Tomioka Yoshihisa
- Journal Title
  
  FEBS Letters
  
  Volume: 591 Issue: 16 Pages: 2406-2416
- DOI
  10.1002/1873-3468.12768
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K20909
[Presentation] マルチオミクス解析から紐解くがん放射線耐性2024
- Author(s)
  金光祥臣、松本雅記
- Organizer
  第144回日本薬学会
- Data Source
  KAKENHI-PROJECT-22K07713
[Presentation] LC-MS/MS を用いたがん細胞の主要メタボローム絶対定量系の構築と代謝解析への応用2023
- Author(s)
  金光祥臣、小林大樹、中谷航太、和泉自泰、馬場健史、松本雅記
- Organizer
  第46回日本分子生物学会年会
- Data Source
  KAKENHI-PROJECT-22K07713
[Presentation] 免疫細胞におけるメトホルミンによる代謝シフトメカニズムのトランスオミクス解析2022
- Author(s)
  出野泉花, 岩崎由希子, 金光祥臣, 丸山順一, 冨田勝, 幡野敦, 柚木克之
- Organizer
  日本分子生物学会年会
- Data Source
  KAKENHI-PROJECT-22K07713
[Presentation] 臨床的放射線耐性細胞を用いた定量プロテオミクス：ヒト口腔扁平上皮癌細胞放射線耐性細胞株 (SAS-R) において Peroxiredoxin 4 が放射線耐性能に重要な役割を担う2021
- Author(s)
  金光祥臣、桑原義和、福本学、富岡佳久、塚本宏樹
- Organizer
  日本放射線影響学会第64回大会
- Data Source
  KAKENHI-PROJECT-19K17258
[Presentation] 放射線耐性がん細胞における Peroxiredoxin 4 を介した放射線耐性の獲得2019
- Author(s)
  後藤裕徳、金光祥臣、桑原義和、福本学、塚本宏樹、富岡佳久
- Organizer
  宮城薬剤師学術フォーラム 2019
- Data Source
  KAKENHI-PROJECT-19K17258
[Presentation] Peroxiredoxin 4は臨床的放射線耐性口腔扁平上皮癌細胞の耐性能に寄与する2019
- Author(s)
  後藤裕徳、金光祥臣、桑原義和、福本学、塚本宏樹、富岡佳久
- Organizer
  第58回日本薬学会東北支部大会
- Data Source
  KAKENHI-PROJECT-19K17258
[Presentation] 多層オミクス手法による放射線耐性化関連分子の探索2018
- Author(s)
  富岡佳久、金光祥臣、松本洋太郎、桑原義和、福本　学、塚本宏樹
- Organizer
  第3回治療耐性がん細胞研究協議会セミナー
- Data Source
  KAKENHI-PROJECT-16K20909
[Presentation] LC-HDMS および IMS を用いたヒト肝癌組織メタボロミクスによる新規バイオマーカーの同定2017
- Author(s)
  永井滉士、三枝大輔、山崎貴広、金光祥臣、塚本宏樹、池田均、矢冨裕、松本洋太郎、富岡佳久
- Organizer
  第56回日本薬学会東北支部大会
- Data Source
  KAKENHI-PROJECT-16K20909
[Presentation] ミックスドモード ODS カラムを用いた LC-MS/MS による尿毒症物質一斉定量系の構築2017
- Author(s)
  金光祥臣、淺地圭、松本洋太郎、塚本宏樹、三枝大輔、阿部高明、富岡佳久
- Organizer
  第56回日本薬学会東北支部大会
- Data Source
  KAKENHI-PROJECT-16K20909
[]
[]
[]

1. TOMIOKA Yoshihisa (00282062)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
2. MATSUMOTO Yotato (90420041)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
3. TSUKAMOTO Hiroki (70423605)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
4. FUKUMOTO Manabu (60156809)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
5. KUWAHARA Yoshikazu (00392225)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
6. 福田真嗣

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
7. 矢吹悌

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Kanemitsu Yoshitomi 金光 祥臣

KANEMITSU Yoshitomi 金光 祥臣

Research Projects

Research Products

Co-Researchers

トランスオミクス解析によるがん細胞の放射線耐性応答ネットワーク解明Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of new therapeutic strategies to overcome cancer radioresistance; focusing on molecules that are increased in resistant cell linesPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Elucidation of the mechanism of radioresistance in cancer cells using trans-omics approach and development of clinical biomarkers for radiotherapy.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Methylmercury directly modifies the 105th cysteine residue in oncostatin M to promote binding to tumor necrosis factor receptor 3 and inhibit cell growth2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] The Disease-modifying Drug Candidate, SAK3 Improves Cognitive Impairment and Inhibits Amyloid beta Deposition in App Knock-in Mice.2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] An inhibitory epitope of human Toll-like receptor 4 resides on leucine-rich repeat 13 and is recognized by a monoclonal antibody2017

Author(s)

Journal Title

DOI

Data Source

[Presentation] マルチオミクス解析から紐解くがん放射線耐性2024

Author(s)

Organizer

Data Source

[Presentation] LC-MS/MS を用いたがん細胞の主要メタボローム絶対定量系の構築と代謝解析への応用2023

Author(s)

Organizer

Data Source

[Presentation] 免疫細胞におけるメトホルミンによる代謝シフトメカニズムのトランスオミクス解析2022

Author(s)

Organizer

Data Source

[Presentation] 臨床的放射線耐性細胞を用いた定量プロテオミクス：ヒト口腔扁平上皮癌細胞放射線耐性細胞株 (SAS-R) において Peroxiredoxin 4 が放射線耐性能に重要な役割を担う2021

Author(s)

Organizer

Data Source

[Presentation] 放射線耐性がん細胞における Peroxiredoxin 4 を介した放射線耐性の獲得2019

Author(s)

Organizer

Data Source

[Presentation] Peroxiredoxin 4は臨床的放射線耐性口腔扁平上皮癌細胞の耐性能に寄与する2019

Author(s)

Organizer

Data Source

[Presentation] 多層オミクス手法による放射線耐性化関連分子の探索2018

Author(s)

Organizer

Data Source

[Presentation] LC-HDMS および IMS を用いたヒト肝癌組織メタボロミクスによる新規バイオマーカーの同定2017

Author(s)

Organizer

Data Source

[Presentation] ミックスドモード ODS カラムを用いた LC-MS/MS による尿毒症物質一斉定量系の構築2017

Author(s)

Organizer

Data Source

[]

Kanemitsu Yoshitomi 金光祥臣

KANEMITSU Yoshitomi 金光祥臣